(Q37684734)

22 August 2017

1 reference

title

Targeting liposomes toward novel pediatric anticancer therapeutics (English)

1 reference

22 August 2017

Noah Federman

1

1 reference

22 August 2017

Christopher T Denny

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

67

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

514-519

1 reference

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e3181d601c5

22 August 2017

exact match

0 references

cites work

Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

The 'right' size in nanobiotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Surrogate cells or Trojan horses. The discovery of liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Liposomal anthracyclines in metastatic breast cancer: clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Pharmacokinetic consequences of pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Endocytic mechanisms for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Nanocarriers' entry into the cell: relevance to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Receptor-mediated delivery of an antisense gene to human brain cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Antibody targeted gene transfer to endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Drug transport to brain with targeted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Use of liposomes as drug delivery vehicles for treatment of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

Emerging gene-directed anti-tumor strategies against human hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181D601C5

10.1203/PDR.0B013E3181D601C5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1020302996

0 references

1 reference